Indianapolis, IN, United States of America

Sophie J Boguslawski

This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Mannheim Gmbh. Active years: 1995-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sophie J Boguslawski. Retrieved from https://idiyas.com/inventor/sophie-j-boguslawski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1995-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sophie J. Boguslawski

Introduction

Sophie J. Boguslawski is a notable inventor based in Indianapolis, IN (US). She has made significant contributions to the field of biotechnology, particularly in the development of enzyme technologies. With a total of 2 patents to her name, her work has had a substantial impact on various applications in the industry.

Latest Patents

Sophie’s latest patents include innovative muteins of β-galactosidase fragments that exhibit increased activity. One patent focuses on muteins of enzyme acceptor polypeptide fragments of β-galactosidase, which show enhanced kinetic complementation activity without significant loss in stability. A preferred enzyme acceptor fragment has an amino acid other than cysteine at position 500, with serine or valine being especially preferred substitutions. Another patent details oxidation-resistant muteins of β-galactosidase fragments, where the enzyme acceptor fragment has an amino acid other than cysteine at position 602, with serine being the preferred substitution. These patents also provide methods for producing the novel muteins and immunoassay methods for determining analytes.

Career Highlights

Sophie J. Boguslawski is currently employed at Boehringer Mannheim GmbH, where she continues to advance her research in enzyme technologies. Her work has been instrumental in developing new methods and compositions that enhance the functionality of β-galactosidase, contributing to the broader field of biotechnology.

Collaborations

Throughout her career, Sophie has collaborated with notable colleagues, including Mark Krevolin and David J. Ledden. These collaborations have fostered a productive environment for innovation and research in enzyme technology.

Conclusion

Sophie J. Boguslawski's contributions to the field of biotechnology through her patents and collaborations highlight her role as a leading inventor. Her work continues to influence advancements in enzyme technologies, showcasing the importance of innovation in this field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…